Zobrazeno 1 - 10
of 801
pro vyhledávání: '"M, Alt"'
Autor:
Susan M. Alt
Critical new discoveries and archaeological patterns increase understanding of early Mississippian culture and society The reasons for the rise and fall of early cities and ceremonial centers around the world have been sought for centuries. In the Un
Autor:
M. Martinot, A. Abou-Bacar, M. Lamothe, M. Alt Tebacher, M. Mohseni Zadeh, F. Dalle, L. Favennec, D. Costa, J. Brunet, F. Sellal
Publikováno v:
BMC Infectious Diseases, Vol 20, Iss 1, Pp 1-4 (2020)
Abstract Background Cryptosporidium sp. are common intracellular parasites responsible of severe diarrhea in T-cell-immunocompromised patients. We report the first case of a woman who contracted cryptosporidiosis after treatment with fingolimod, a dr
Externí odkaz:
https://doaj.org/article/480215027f8445d69c483b056c2d1424
Publikováno v:
Statistics in Medicine. 42:1722-1740
Autor:
Christopher H. Calvey, Violeta Sànchez i Nogué, Aleena M. White, Colin M. Kneucker, Sean P. Woodworth, Hannah M. Alt, Carrie A. Eckert, Christopher W. Johnson
Publikováno v:
Metabolic Engineering. 75:78-90
Conversion of CO
Publikováno v:
JAWRA Journal of the American Water Resources Association. 59:244-256
Publikováno v:
Statistics in Medicine. 42:1-14
We develop the scale transformed power prior for settings where historical and current data involve different data types, such as binary and continuous data. This situation arises often in clinical trials, for example, when historical data involve bi
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Biostatistics
Summary There has been increased interest in using prior information in statistical analyses. For example, in rare diseases, it can be difficult to establish treatment efficacy based solely on data from a prospective study due to low sample sizes. To
Publikováno v:
Biostatistics
Summary In clinical trials, it is common to have multiple clinical outcomes (e.g., coprimary endpoints or a primary and multiple secondary endpoints). It is often desirable to establish efficacy in at least one of multiple clinical outcomes, which le